Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study

被引:0
|
作者
Ralf W. Dittmann
Esther Cardo
Peter Nagy
Colleen S. Anderson
Ralph Bloomfield
Beatriz Caballero
Nicholas Higgins
Paul Hodgkins
Andrew Lyne
Richard Civil
David Coghill
机构
[1] University of Heidelberg,Paediatric Psychopharmacology, Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim
[2] University of the Balearic Islands,Son Llàtzer Hospital and Research Institute on Health Sciences
[3] Vadaskert Child and Adolescent Psychiatry Hospital and Outpatient Clinic,Division of Neuroscience
[4] Shire Development LLC,undefined
[5] Shire Pharmaceutical Development Ltd,undefined
[6] Shire AG,undefined
[7] University of Dundee,undefined
来源
CNS Drugs | 2013年 / 27卷
关键词
Atomoxetine; Guanfacine; ADHD Medication; Lisdexamfetamine; Amfetamine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1081 / 1092
页数:11
相关论文
共 50 条
  • [11] Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study
    Biederman, Joseph
    Krishnan, Suma
    Zhang, Yuxin
    McGough, James J.
    Findling, Robert L.
    CLINICAL THERAPEUTICS, 2007, 29 (03) : 450 - 463
  • [12] Phase II/III Study of Lisdexamfetamine Dimesylate in Japanese Pediatric Patients with Attention-Deficit/Hyperactivity Disorder
    Ichikawa, Hironobu
    Miyajima, Tasuku
    Yamashita, Yushiro
    Fujiwara, Masakazu
    Fukushi, Akimasa
    Saito, Kazuhiko
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020, 30 (01) : 21 - 31
  • [13] A randomized, double-blind study of continuation treatment for attention-deficit hyperactivity disorder after 1 year
    Buitelaar, Jan K.
    Michelson, David
    Danckaerts, Marina
    Gillberg, Christopher
    Spencer, Thomas J.
    Zuddas, Alessandro
    Faries, Douglas E.
    Zhang, Shuyu
    Biederman, Joseph
    BIOLOGICAL PSYCHIATRY, 2007, 61 (05) : 694 - 699
  • [14] Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the Effects of Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts on Cognition Throughout the Day in Adults with Attention-Deficit/Hyperactivity Disorder
    Patrick T. Martin
    Mary Corcoran
    Pinggao Zhang
    Alain Katic
    Clinical Drug Investigation, 2014, 34 : 147 - 157
  • [15] A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK
    Zimovetz, Evelina A.
    Joseph, Alain
    Ayyagari, Rajeev
    Mauskopf, Josephine A.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2018, 19 (01) : 21 - 35
  • [16] Efficacy and safety of atomoxetine hydrochloride in Korean adults with attention-deficit hyperactivity disorder
    Lee, Soyoung Irene
    Song, Dong-Ho
    Shin, Dong Won
    Kim, Ji Hoon
    Lee, Young Sik
    Hwang, Jun-Won
    Park, Tae Won
    Yook, Ki-Hwan
    Lee, Jong Il
    Bahn, Geon Ho
    Hirata, Yuko
    Goto, Taro
    Takita, Yasushi
    Takahashi, Michihiro
    Lee, Sanghoon
    Treuer, Tamas
    ASIA-PACIFIC PSYCHIATRY, 2014, 6 (04) : 386 - 396
  • [17] A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK
    Evelina A. Zimovetz
    Alain Joseph
    Rajeev Ayyagari
    Josephine A. Mauskopf
    The European Journal of Health Economics, 2018, 19 : 21 - 35
  • [18] Multidimensional Comparison of Methylphenidate and Atomoxetine in the Treatment of Attention-Deficit/ Hyperactivity Disorder in Children, a 12-Week, Open-Label, Head-to-Head Clinical Trial
    Chen, Lin
    Du, Wenran
    PSYCHIATRY INVESTIGATION, 2025, 22 (02) : 140 - 147
  • [19] Efficacy and Safety of Atomoxetine in the Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder
    Kohn, Michael R.
    Tsang, Tracey W.
    Clarke, Simon D.
    CLINICAL MEDICINE INSIGHTS-PEDIATRICS, 2012, 6 : 95 - 162
  • [20] Atomoxetine Treatment of Attention-Deficit/Hyperactivity Disorder in Young Adults With Assessment of Functional Outcomes A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Durell, Todd M.
    Adler, Lenard A.
    Williams, Dave W.
    Deldar, Ahmed
    McGough, James J.
    Glaser, Paul E.
    Rubin, Richard L.
    Pigott, Teresa A.
    Sarkis, Elias H.
    Fox, Bethany K.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (01) : 45 - 54